Table 2.
The latency time in the APP/PSI mice with AD.
| Group | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 |
|---|---|---|---|---|---|
| Control (n = 10) | 60.00 ± 0.00 | 59.33 ± 1.15 | 30.6 ± 11.96 | 13.43 ± 3.76 | 10.53 ± 4.64 |
| Model group (n = 10) | 60.00 ± 0.00 | 54.77 ± 8.89 | 50.9 ± 13.25# | 50.87 ± 14.87## | 50.37 ± 15.91## |
| Donepezil group (n = 10) | 57.23 ± 1.66 | 58.10 ± 3.12 | 36.23 ± 9.58∗ | 42.17 ± 17.85 | 46.57 ± 11.68 |
| PhG high-dose group (n = 10) | 45.47 ± 20.20 | 38.3 ± 19.19 | 35.6 ± 16.68 | 22.57 ± 16.74∗ | 18.23 ± 8.82∗∗ |
| PhG moderate-dose group (n = 10) | 53.43 ± 6.92 | 44.9 ± 13.55 | 39.5 ± 27.62 | 29.67 ± 26.46∗ | 25.90 ± 28.84∗ |
| PhG low-dose group (n = 10) | 60.00 ± 0.00 | 58.57 ± 2.48 | 45.7 ± 19.98 | 34.17 ± 24.72 | 21.40 ± 9.79∗ |
| Verbascose group (n = 10) | 55.21 ± 7.48 | 42.23 ± 15.20 | 35.85 ± 11.39 | 28.77 ± 19.47∗ | 23.66 ± 18.29∗ |
## P < 0.01 vs. the control; #P < 0.05 vs. the control; ∗∗P < 0.01 vs. the model group; ∗P < 0.05 vs. the model group.